Marinus Pharmaceuticals   Report issue

Contributed to NME For profit Phase 3
Founded: Branford CT United States (2003)

Organization Overview

First Clinical Trial
2007
NCT00442104
First Marketed Drug
2022
ganaxolone (Ztalmy)
First NDA Approval
2022
ganaxolone (Ztalmy)
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

MARINUS | Marinus Pharmaceuticals | Marinus Pharmaceuticals, Inc.